These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28071741)

  • 21. Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease.
    Abrams CK; Freidin MM; Verselis VK; Bennett MV; Bargiello TA
    Brain Res; 2001 May; 900(1):9-25. PubMed ID: 11325342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.
    Wang HL; Chang WT; Yeh TH; Wu T; Chen MS; Wu CY
    Neurobiol Dis; 2004 Mar; 15(2):361-70. PubMed ID: 15006706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CMT1X phenotypes represent loss of GJB1 gene function.
    Shy ME; Siskind C; Swan ER; Krajewski KM; Doherty T; Fuerst DR; Ainsworth PJ; Lewis RA; Scherer SS; Hahn AF
    Neurology; 2007 Mar; 68(11):849-55. PubMed ID: 17353473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of gap junction mutations in myelinating cells.
    Sargiannidou I; Markoullis K; Kleopa KA
    Histol Histopathol; 2010 Sep; 25(9):1191-206. PubMed ID: 20607661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent CNS dysfunction in a boy with CMT1X.
    Siskind C; Feely SM; Bernes S; Shy ME; Garbern JY
    J Neurol Sci; 2009 Apr; 279(1-2):109-13. PubMed ID: 19193385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypes of X-linked Charcot-Marie-Tooth disease and altered trafficking of mutant connexin 32 (GJB1).
    Matsuyama W; Nakagawa M; Moritoyo T; Takashima H; Umehara F; Hirata K; Suehara M; Osame M
    J Hum Genet; 2001; 46(6):307-13. PubMed ID: 11393532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Two novel mutations of GJB1 gene associated with typical X-linked Charcot-Marie-Tooth disease].
    Qiao XH; Li YX; Chang XZ; Luan XH; Chen B; Bu DF; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3328-31. PubMed ID: 20193560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X.
    Kagiava A; Richter J; Tryfonos C; Karaiskos C; Heslegrave AJ; Sargiannidou I; Rossor AM; Zetterberg H; Reilly MM; Christodoulou C; Kleopa KA
    Hum Mol Genet; 2019 Nov; 28(21):3528-3542. PubMed ID: 31411673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional requirement for a highly conserved charged residue at position 75 in the gap junction protein connexin 32.
    Abrams CK; Islam M; Mahmoud R; Kwon T; Bargiello TA; Freidin MM
    J Biol Chem; 2013 Feb; 288(5):3609-19. PubMed ID: 23209285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling studies in regenerating nerves in a mouse model for CMT1X: uninjured Cx32-knockout peripheral nerves display expression profile of injured wild type nerves.
    Freidin M; Asche-Godin S; Abrams CK
    Exp Neurol; 2015 Jan; 263():339-49. PubMed ID: 25447941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diseases of connexins expressed in myelinating glia.
    Abrams CK
    Neurosci Lett; 2019 Mar; 695():91-99. PubMed ID: 28545922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent central nervous system white matter changes in charcot-Marie-tooth type X disease.
    McKinney JL; De Los Reyes EC; Lo WD; Flanigan KM
    Muscle Nerve; 2014 Mar; 49(3):451-4. PubMed ID: 24170412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gap junction disorders of myelinating cells.
    Kleopa KA; Orthmann-Murphy J; Sargiannidou I
    Rev Neurosci; 2010; 21(5):397-419. PubMed ID: 21280457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What's the Function of Connexin 32 in the Peripheral Nervous System?
    Bortolozzi M
    Front Mol Neurosci; 2018; 11():227. PubMed ID: 30042657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gap junctions in inherited human disorders of the central nervous system.
    Abrams CK; Scherer SS
    Biochim Biophys Acta; 2012 Aug; 1818(8):2030-47. PubMed ID: 21871435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual features of central nervous system involvement in CMTX associated with a novel mutation of GJB1 gene.
    Stancanelli C; Taioli F; Testi S; Fabrizi GM; Arena MG; Granata F; Russo M; Gentile L; Vita G; Mazzeo A
    J Peripher Nerv Syst; 2012 Dec; 17(4):407-11. PubMed ID: 23279342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease.
    Abrams CK; Bennett MV; Verselis VK; Bargiello TA
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3980-4. PubMed ID: 11891346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy.
    Kagiava A; Karaiskos C; Richter J; Tryfonos C; Jennings MJ; Heslegrave AJ; Sargiannidou I; Stavrou M; Zetterberg H; Reilly MM; Christodoulou C; Horvath R; Kleopa KA
    Gene Ther; 2021 Nov; 28(10-11):659-675. PubMed ID: 33692503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins.
    VanSlyke JK; Deschenes SM; Musil LS
    Mol Biol Cell; 2000 Jun; 11(6):1933-46. PubMed ID: 10848620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.